Tue, Jul 22, 2014, 3:45 PM EDT - U.S. Markets close in 15 mins.

Recent

% | $
Click the to save as a favorite.

Galena Biopharma, Inc. Message Board

  • o00oo000 o00oo000 Nov 27, 2012 11:41 AM Flag

    Some people never learn........... and yes, They pay dearly ...................

    That is why never fall for fake pumps ( especially if they are made by cheerleader little guy with their couple thousand dollars.
    Some experienced ones here warned you for this stock when pumped by mostly little guys (I mentioned above) we said dont fall for it way too many red flags;
    No money (15 mil. is nothing for phase3 study)
    No partnership
    Share dilution is about to happen
    Kriegsman factor( big red flag)
    Ahn ( what he did to TLON )
    No institutional ownership( lessthan 6%)
    No insider ownership( 1% , LOL, if they believed it they would own it, simple as that)
    High short interest.

    That is why you always need to do due diligence, never fall for cheerleaders' pumps. Most are in big red now they didnt listen and bought couple weeks ago above 2 and now they are in desperation mode.I am sorry to say these especially when people losing their money but this stock's pump was so obvious and clear, it was like day and night.
    And slide will continue in following days, weeks,months

    if you already bought sell and cut your loses ( lick your wounds and take this as a learning lesson)
    if you are on the sidelines waiting, keep waiting till share offering or drop to $1 ( whicever comes first)
    You will be glad you did

    good luck (ofcourse luck has nothing to do with it)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALE
2.8701+0.0801(+2.87%)3:45 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.